-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Xeris Biopharma Holdings, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2020 to Q2 2024.
- Xeris Biopharma Holdings, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $4.23M, a 44.6% increase year-over-year.
- Xeris Biopharma Holdings, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $13.2M, a 18.1% increase year-over-year.
- Xeris Biopharma Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $10.7M, a 11.9% decline from 2022.
- Xeris Biopharma Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $12.2M, a 6.85% increase from 2021.
- Xeris Biopharma Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $11.4M, a 37.6% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)